hoods better to tell their stories than - Allegheny West Magazine
hoods better to tell their stories than - Allegheny West Magazine
hoods better to tell their stories than - Allegheny West Magazine
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
44 <strong>Allegheny</strong> <strong>West</strong> <strong>Magazine</strong> September/Oc<strong>to</strong>ber 2012<br />
Heritage Valley News<br />
The American College of Endocrinology (ACE), the educational and<br />
scientific arm of the American Association of Clinical Endocrinologists<br />
(AACE), inducted Heritage Valley Health System Endocrinologist Noah<br />
Lubowsky, MD, FACE as a Fellow during its 20 th Annual Convocation<br />
ceremony.<br />
The Heritage Valley Sewickley Foundation welcomed Terri Tunick<br />
and Susan Cox <strong>to</strong> its Board of Direc<strong>to</strong>rs.<br />
Terri Tunick is a retired nurse manager and educa<strong>to</strong>r and is active<br />
with several community organizations. She also coordinates the<br />
annual Unique Boutique fundraising event for Heritage Valley<br />
Sewickley Foundation, which will be held this year at the Edgeworth<br />
Club on November 10.<br />
Susan Cox is a former New York City public schools teacher and<br />
continues <strong>to</strong> serve in various educational roles at Edgeworth<br />
Elementary. She is also involved with several community activities and<br />
organizations in the Sewickley area.<br />
Neither aspirin nor warfarin is superior for preventing a combined risk<br />
of death, stroke, and cerebral hemorrhage in heart failure (HF) patients<br />
with normal heart rhythm, according <strong>to</strong> the ten-year WARCEF (Warfarin<br />
and Aspirin for Reduced Cardiac Ejection Fraction) trial. The trial, which<br />
was supported by the National Institute for Neurological Disorders and<br />
Stroke, part of the National Institutes of Health, was published May 2 in<br />
the New England Journal of Medicine.<br />
The WARCEF trial is the largest double-blind comparison of these<br />
medications for heart failure, including 2,305 patients for up <strong>to</strong> six years<br />
at 168 study sites in 11 countries on three continents. The Heritage<br />
Valley Heart & Vascular Center, part of Heritage Valley Health System,<br />
was one of the lead participating sites, having been involved with the<br />
WARCEF trial since 2006.